Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase.
Yoshio Honma(National Cancer Center Hospital East), Yoshisada Miura(Jichi Medical University), Takashi Kasukabe(Shimane University), Sachiko Kajigaya(National Heart Lung and Blood Institute), Junko Okabe‐Kado(Saitama Cancer Center), Motoo Hozumi, Hiroaki Kodama(SHOWA Medical University), Toshio Suda(Chinese Academy of Sciences)
PubMed
July 15, 1992
Cited by 24
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771